Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigation of Efficacy and Tolerability of Levetiracetam for Epilepsy in Elderly

NCT07422233 is registered in ClinicalTrials.gov with Nasim Tabrizi as lead sponsor.

NCT NCT07422233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07422233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigation of Efficacy and Tolerability of Levetiracetam for Epilepsy in Elderly
Lead sponsor
Nasim Tabrizi
Phase
Phase 4
Overall status
Completed
Start date
September 13, 2023
Completion date
January 20, 2026
Enrollment
137 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

elderly, epilepsy